Abdusaid Saidahmatov

Statistics

Publications

Citations

144

H-Index

Active since

2021

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

University of Chinese Academy of Sciences

Abdusaid Saidahmatov is an author at Shanghai Institute of Materia Medica specializing in medicinal chemistry, drug discovery, and oncology pharmacology.

Publications per year

2021–2024

Publications

Discovery of Novel Pyrrolo[2,3-<i>d</i>]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors

Xuewu Liang, Shuai Tang, Xuyi Liu et al. · Journal of Medicinal Chemistry · 2021 · 67 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Synthesis of Pyrazolo[1,2‐a]cinnolines <i>via</i> Rhodium(III)‐Catalyzed [4+2] Annulation Reactions of Pyrazolidinones with Sulfoxonium Ylides

Shulei Hu, Xu Han, Xiong Xie et al. · Advanced Synthesis & Catalysis · 2021 · 32 citations

Natural Sciences, Chemistry, Medicinal Chemistry +8

Rational Design and Development of Novel CDK9 Inhibitors for the Treatment of Acute Myeloid Leukemia

Xu Han, Ning Song, Abdusaid Saidahmatov et al. · Journal of Medicinal Chemistry · 2021 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

Discovery of Novel 2-Aminopyridine-Based and 2-Aminopyrimidine-Based Derivatives as Potent CDK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors and Hematological Malignancies

Abdusaid Saidahmatov, Jianan Li, Jianan Li et al. · Journal of Medicinal Chemistry · 2024 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

1–4 of 4